Overview

Study of Radiotracer [18F]Fluortriopride ([18F]FTP) by PET/CT

Status:
Active, not recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
In this phase 1 pilot study, positron emission tomography (PET/CT) imaging will be used to determine the biodistribution, metabolism and excretion of a novel radiotracer [18F]Fluortriopride ([18F]FTP).
Phase:
Phase 1
Details
Lead Sponsor:
University of Pennsylvania